Company intelligence / Profile preview

Tygrus

Troy, Michigan, United States
Ownership
Private
Employees
~16
Development stage
Other
01

Overview

Tygrus is a private U.S. life science, research and development, manufacturing, and licensing company developing patented specialty chemistries intended to replace hazardous disinfectants, preservatives, and other toxic chemicals with safer alternatives. The company markets itself as a platform business built around its proprietary Tydronium chemistry and applies that platform across multiple sectors including respiratory therapeutics, personal care, food safety, agriculture, and industrial applications. In healthcare-related applications, Tygrus highlights respiratory therapeutics and anti-infective chemistry such as Tydracin, with licensing discussions for Miracus expected to target pharmaceutical companies with respiratory portfolios. The company also operates an 18,000 square foot manufacturing facility in Madison Heights, Michigan and pursues a global licensing model. Overall, Tygrus appears to be a diversified chemical innovation company with some healthcare exposure rather than a pure-play clinical biotech.

Therapeutic areas
OtherInfectious Diseases
Modalities
Small moleculeDevice
Industry
Biotech
02

Drug pipeline

1 asset

Tydracin

Unknown
03

Partnerships

Ethos Asset Management

Beyond the preview

Go deeper on Tygrus.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tygrus.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call